ADVERUM BIOTECHNOLOGIES, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 20 Debt SecuritiesIndenture • August 8th, 2019 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 8th, 2019 Company Industry JurisdictionINDENTURE, dated as of [●], 20 , among Adverum Biotechnologies, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
ADVERUM BIOTECHNOLOGIES, INC. AND , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OFPreferred Stock Warrant Agreement • August 8th, 2019 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 8th, 2019 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between ADVERUM BIOTECHNOLOGIES, INC., a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
ADVERUM BIOTECHNOLOGIES, INC. AND , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFWarrant Agreement • August 8th, 2019 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 8th, 2019 Company Industry JurisdictionTHIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between ADVERUM BIOTECHNOLOGIES, INC., a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
ADVERUM BIOTECHNOLOGIES, INC. AND , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OFWarrant Agreement • August 8th, 2019 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 8th, 2019 Company Industry JurisdictionTHIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between ADVERUM BIOTECHNOLOGIES, INC., a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).